-
Arthritis consists of more than 100 different conditions, the most common being osteoarthritis (degenerative joint disease), fibromyalgia, gout, and rheumatoid arthritis (also an autoimmune disease). The symptoms associated with arthritis are pain or tenderness in the joints, inflammation, and stiffness. Arthritis also causes breakdown of cartilage, which normally protects a joint, allowing it to move smoothly. When cartilage breaks down, bones rub together and create pain and inflammation. Arthritis can be acute or chronic. In the former case, the cause is found and treated or just goes away. In the latter case, the cause is never identified and a person lives for years or the rest of their lives with arthritis.
The common symptoms of arthritis are:
- Joint pain
- Joint swelling
- Reduced ability to move the joint
- Redness of the skin around a joint
- Stiffness, especially in the morning
- Warmth around a joint
Solutions include lifestyle changes, such as getting more low-impact aerobic exercise, range of motion exercises, sleeping 8 to 10 hours per night, changing the home to make activities easier, and eating healthier foods and foods rich in omega-3 fatty acids (which are prevalent in hemp oil). Physical therapy, massage, water therapy, and heat or ice are also beneficial.
In animals, it has been found that "Cannabinoids have analgesic, immunomodulatory and anti-inflammatory properties and attenuate joint damage in animal models of arthritis" ("Arthritis and Cannabinoids: HU-210 and Win-55, 212-2 Prevent IL-1Alpha-Induced Matrix Degradation in Bovine Articular Chondrocytes In-Vitro," a study by the Biomedical Research Centre at Sheffield Hallam University in England). In another study, "Cannabinoids in the Management of Difficult to Treat Pain," conducted by the company GW Pharmaceuticals, states:
Sativex ®, a cannabis derived oromucosal spray containing equal proportions of THC (partial CB1) receptor agonist ) and cannabidiol (CBD, a non-euphoriant, anti-inflammatory analgesic with CB1 receptor antagonist and endocannabinoid modulating effects) was approved in Canada in 2005 for treatment of central neuropathic pain in multiple sclerosis, and in 2007 for intractable cancer pain. Numerous randomized clinical trials have demonstrated safety and efficacy for Sativex in central and peripheral neuropathic pain, rheumatoid arthritis and cancer pain. An Investigational New Drug application to conduct advanced clinical trials for cancer pain was approved by the US FDA in January 2006. Cannabinoid analgesics have generally been well tolerated in clinical trials with acceptable adverse event profiles. Their adjunctive addition to the pharmacological armamentarium for treatment of pain shows great promise.
These are compelling reports that show promise for treating arthritis with cannabinoids.
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002223/
-
Category
Critical Ailments -
Created
Thursday, 16 March 2017 -
Group admin
CBIS
1- Million Strong Killing Cancers Foundation & Fight Club!
We are LIVE !!! Join the FIGHT NOW! with Harvard Award Winning,
Low-Cost Cancer-Killing Treatments! Click the Above Image link to setup your Account and begin your Crypto Journey with us. The 1-Million Strong Killing Cancers Foundation, the 1-Million Strong Fight Club, & CSi Labs are making cancer treatments affordable and accessible for millions of patients through our innovative cancer killing fundraising meme token. All Crypto MEME Coin Purchases will be included in the Up and Coming Contests and Promotions!
The Time is Now. 1-Million Strong Killing Cancers!
Click the Below Image to Review our Cancer Drug Comparables
*** Warning this document contains graphic images.
CSi-VIP Awards & NASDAQ Updates
Please Click the Below Image:
1st HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.
2nd HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.
*** PLUS
(3) other Cannabis Science
REAL WORLD Successes:
Stage 4 Breast Cancer
Skin Cancer
Karposis Sarcoma
The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
Photos
Observational Studies
CSi-VIP & CBIS-Shareholder Legacy
Please Click the Below Calendar image to book your time to speak with Mr. Dabney about Your CSi-VIP Shareholder Legacy & 1-Million Strong Membership.
One LAST TIME … for CLARITY …
CBIS Original Shareholders - CBIS First Rights, CSi-VIP Bonus Shares, CBIS GIFT Shares, CSi-VIP Drug Ownership Program ...
*** CSi-VIP AWARDS Program !!!
MAKE SURE … You have Your CSi-VIP Membership!
Click the Above image: February 4, 2026, Cannabis Science Inc., Shareholder Close-out. All Cannabis Science Shareholders Qualify.
Above ANNOUNCEMENT: December 31, 2025, Cannabis Science Inc., Shareholder Close-out.
Cannabis Science Financials & FINAL CBIS/CSi-VIP Share Numbers. Click the above Image link to view the latest Report.
November 5, 2025
Cannabis Science Shareholder FINAL Audit Confirmations
Click the above Image link to view the latest Report
September 23, 2025
Cannabis Science Shareholder Audit Confirmations Underway now!
Click the above Image link to view the latest Report.
July 7, 2025
Click the above Image link to view the latest cancer Killing promotional video. This is where you can join our 1-Million Strong youtube page to view more videos as we proceed forward.
June 1, 2025, Pre-Launch Success
Click the above Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time offer!
Click the ABOVE Image to Review our 1-Million Strong FC, Media Kit
*** Warning this document contains exciting images.
Click the above Image to become one of the First 1-Million Strong Killing Cancers, Fight Club Members to help 'Make that Change' Join in Now! *** Warning this Membership contains Exciting Results.
PS ... ALL of our CSi-VIP's and those who Donated through the ASU/CSi-EDP GO-Fund-Me Promotion you do not need to purchase anything, you are ALREADY included in the "First" 1-Million Membership Club, CONGRATULATIONS !!!
Cannabis Science CEO, Presents …
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 2024, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.
2025 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2025
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,839,095,296
Fully Diluted:
4,510,547,648
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!
Activity Stream
RAYMOND, PLEASE RESPOND TO MY EMAIL! ...Francis G. Cormier III
In 2021, a share exchange was initiated through Thermic Science International...
Show more
Raymond,
Any update on when our CBIS shares can trade again?
